TBJ Covers 2021 People to Watch: BioAgilytix CEO Jim Datin

In this news article, TBJ covers in depth the history and achievements of BioAgilytix’ CEO, Jim Datin. He has been at the helm of BioAgilytix since November 2013 and has put BioAgilytix on the path of growth and expansion.

Featured Expert

Pharmacokinetics & Pharmacodynamics​

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.
220328 Adleverage_Scientific Icon Illustrations_#46-65_CO_Per FIles